About Us
Company Introduction Strategic Development Social Responsibility
Scientific Research
Innovative Layout Innovative Field
International
Global Expansion Cooperative Partner Global R&D Centers International Cooperation
Investor Relations
Information Disclosure Corporate Governance Stock Information ESG Contact us
Products Services
Product center Product branding Quality & Safety
News
Company News Media Coverage Media Inquiries Multimedia zone
Career
Talent R&D Team Employee Life Job Opportunities
EN
CN
About Us
· Company Introduction · Strategic Development · Social Responsibility
Scientific Research
· Innovative Layout · Innovative Field
Products Services
· Product center · Product branding · Quality & Safety
News
· Company News · Media Coverage · Media Inquiries · Multimedia zone
Vocational
· Concept about Talent · R&D Team · Employee Life · Job Opportunities
> News > Company
Return
Grand Pharma Supports China Dean’s Conference to Deepen the Practice of “Three Doctors’ Cooperation
2024-08-29

On August 24, The 13th CHDF, organized by Heilongjiang Health Development Research Center and The Journal of Chinese Hospital Management, and supported by Grand Pharma, was held in Harbin. The 13th CHDF, which was organized by Heilongjiang Health Development Research Center and The Journal of Chinese Hospital Management, and supported by Grand Pharma, was held in the International Conference Center of Harbin Huaqi Hotel.

The forum gathered medical management elites and experts and scholars from all over the country to discuss how to further improve the capacity of clinical specialties under the drive of new quality productivity in the medical field, so as to provide patients with more high-quality and efficient medical services.

Prev

Next

Related news

  • <em>The Phase IIa Clinical Study Conducted in China of Grand Pharma’s Global Innovative Ophthalmic Drug GPN00884 Has Completed the First Patient Enrollment</em>
    The Phase IIa Clinical Study Conducted in China of Grand Pharma’s Global Innovative Ophthalmic Drug GPN00884 Has Completed the First Patient Enrollment

    2025-10-26

  • The Registration Clinical Study Conducted in China of the Global Innovative Temperature-Sensitive Embolic Agent Has Completed All Patients Enrollment
    The Registration Clinical Study Conducted in China of the Global Innovative Temperature-Sensitive Embolic Agent Has Completed All Patients Enrollment

    2025-10-09

  • Grand Pharma’s Treprostinil Injection Has Been Granted a Drug Registration Certificate by NMPA
    Grand Pharma’s Treprostinil Injection Has Been Granted a Drug Registration Certificate by NMPA

    2025-09-24

Grand Pharma Group
About Us
Company Introduction Strategic Development Social Responsibility
Scientific Research
Innovative Layout Innovative Field
International
Global expansion Cooperative Partner Global R&D Centers International Cooperation
Investor Relations
Information Disclosure Corporate Governance Stock Information Contact us
Products Services
Product Center Product branding Quality & Safety
News
Company News Media Coverage Media Inquiries Multimedia zone
Vocational
Concept about Talent R&D Team Employee Life Job Opportunities
Copyright © Grand Pharma (China) Co., Ltd. All Rights Reserved E ICP B 10008288 EGWAB 42010402000597
Legal Provisions